Literature DB >> 19164886

Direct detection of disease associated prions in brain and lymphoid tissue using antibodies recognizing the extreme N terminus of PrPC.

Geoff Barnard1, Lee Hopkins, Sowmiya Moorthie, David Seilly, Paul Tonks, Reza Dabaghian, Jonathan Clewley, John Coward, Ian McConnell.   

Abstract

A simple diagnostic test is described for the detection of TSE in bovine, ovine and human brain and lymphoid tissue that obviates the use of proteinase K as a discriminating reagent. The immunoassay utilises high affinity anti-peptide antibodies that appear blind to the normal isoform of prion protein (PrP(C)). These reagents have been produced with novel N-terminal chimeric peptides and we hypothesise that the retention and stability of the extreme N-terminus of PrP in the disease-associated aggregate makes it an operationally specific marker for TSE. Accordingly, the assay involves homogenisation of the tissue directly in 8M guanidine hydrochloride, a simple one-step capture of PrP(Sc) followed by detection with a europium-labelled anti-PrP(C) antibody. This rapid assay clearly differentiates between levels of disease-associated PrP extracted from brain and lymphoid tissues taken from confirmed TSE positive and negative cattle and sheep. The assay can also be used to detect PrP(Sc) in cases of vCJD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19164886      PMCID: PMC2634452          DOI: 10.4161/pri.1.2.4439

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  27 in total

1.  Tests for BSE evaluated. Bovine spongiform encephalopathy.

Authors:  J Moynagh; H Schimmel
Journal:  Nature       Date:  1999-07-08       Impact factor: 49.962

2.  Efficiency of Western blotting for the specific immunodetection of proteinase K-resistant prion protein in BSE diagnosis in France.

Authors:  J Y Madec; P Belli; D Calavas; T Baron
Journal:  Vet Rec       Date:  2000-01-15       Impact factor: 2.695

3.  Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis.

Authors:  Mark Kristiansen; Marcus J Messenger; Peter-Christian Klöhn; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge; Sarah J Tabrizi
Journal:  J Biol Chem       Date:  2005-09-12       Impact factor: 5.157

4.  Eight prion strains have PrP(Sc) molecules with different conformations.

Authors:  J Safar; H Wille; V Itri; D Groth; H Serban; M Torchia; F E Cohen; S B Prusiner
Journal:  Nat Med       Date:  1998-10       Impact factor: 53.440

5.  Sensitivity of the Western blot detection of prion protein PrPres in natural sheep scrapie.

Authors:  J Y Madec; M H Groschup; A Buschmann; P Belli; D Calavas; T Baron
Journal:  J Virol Methods       Date:  1998-11       Impact factor: 2.014

Review 6.  New protein engineering approaches to multivalent and bispecific antibody fragments.

Authors:  A Plückthun; P Pack
Journal:  Immunotechnology       Date:  1997-06

7.  Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay.

Authors:  Alana M Thackray; Lee Hopkins; Raymond Bujdoso
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

8.  Validation of a western immunoblotting procedure for bovine PrP(Sc) detection and its use as a rapid surveillance method for the diagnosis of bovine spongiform encephalopathy (BSE).

Authors:  O Schaller; R Fatzer; M Stack; J Clark; W Cooley; K Biffiger; S Egli; M Doherr; M Vandevelde; D Heim; B Oesch; M Moser
Journal:  Acta Neuropathol       Date:  1999-11       Impact factor: 17.088

9.  Application of Prionics Western blotting procedure to screen for BSE in cattle regularly slaughtered at Swiss abattoirs.

Authors:  B Oesch; M Doherr; D Heim; K Fischer; S Egli; S Bolliger; K Biffiger; O Schaller; M Vandevelde; M Moser
Journal:  Arch Virol Suppl       Date:  2000

10.  Prion (PrPSc)-specific epitope defined by a monoclonal antibody.

Authors:  C Korth; B Stierli; P Streit; M Moser; O Schaller; R Fischer; W Schulz-Schaeffer; H Kretzschmar; A Raeber; U Braun; F Ehrensperger; S Hornemann; R Glockshuber; R Riek; M Billeter; K Wüthrich; B Oesch
Journal:  Nature       Date:  1997-11-06       Impact factor: 49.962

View more
  5 in total

Review 1.  Neurotheranostics as personalized medicines.

Authors:  Bhavesh D Kevadiya; Brendan M Ottemann; Midhun Ben Thomas; Insiya Mukadam; Saumya Nigam; JoEllyn McMillan; Santhi Gorantla; Tatiana K Bronich; Benson Edagwa; Howard E Gendelman
Journal:  Adv Drug Deliv Rev       Date:  2018-10-26       Impact factor: 15.470

2.  Huaier Extract Induces Autophagic Cell Death by Inhibiting the mTOR/S6K Pathway in Breast Cancer Cells.

Authors:  Xiaolong Wang; Wenwen Qi; Yaming Li; Ning Zhang; Lun Dong; Mingjuan Sun; Jinjing Cun; Yan Zhang; Shangge Lv; Qifeng Yang
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

Review 3.  Peptides, Antibodies, Peptide Antibodies and More.

Authors:  Nicole Trier; Paul Hansen; Gunnar Houen
Journal:  Int J Mol Sci       Date:  2019-12-13       Impact factor: 5.923

4.  Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activation.

Authors:  Hui-Chuan Yu; Chen-Si Lin; Wei-Tien Tai; Chun-Yu Liu; Chung-Wai Shiau; Kuen-Feng Chen
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

5.  Huaier extract synergizes with tamoxifen to induce autophagy and apoptosis in ER-positive breast cancer cells.

Authors:  Wenwen Qi; Mingjuan Sun; Xiangnan Kong; Yaming Li; Xiaolong Wang; Shangge Lv; Xia Ding; Sumei Gao; Jinjing Cun; Chang Cai; Xiaoting Wang; Junfei Chen; Aijun Yin; Qifeng Yang
Journal:  Oncotarget       Date:  2016-05-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.